Download Citation
Article Source:
Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives
Arrieta A,
Page TF,
Veledar E,
Nasir K
(2017)
Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives.
PLOS ONE 12(1): e0169761.
https://doi.org/10.1371/journal.pone.0169761